Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,33 USD | -0,43% | +2,16% | -10,11% |
Omzet 2024 * | 695 mln. 641 mln. | Omzet 2025 * | 760 mln. 701 mln. | Marktkapitalisatie | 1,41 mld. 1,3 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 58 mln. 53,48 mln. | Nettowinst (verlies) 2025 * | 82 mln. 75,61 mln. | EV/omzet 2024 * | 2,31 x |
Nettoschuld 2024 * | 196 mln. 181 mln. | Nettoliquiditeiten 2025 * | 49,54 mln. 45,68 mln. | EV/omzet 2025 * | 1,79 x |
K/w-verhouding 2024 * |
24,9
x | K/w-verhouding 2025 * |
15,9
x | Werknemers | 712 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,74% |
Recentste transcriptie over Pacira BioSciences, Inc.
1 dag | -0,43% | ||
1 week | +2,16% | ||
1 maand | +12,54% | ||
3 maanden | +5,09% | ||
6 maanden | +9,06% | ||
Lopend jaar | -10,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 56 | 02/01 |
Charles Reinhart
DFI | Director of Finance/CFO | 63 | 01-11-11 |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 76 | 01-06-08 |
Paul Hastings
CHM | Chairman | 64 | 02-06-11 |
Andreas Wicki
BRD | Director/Board Member | 64 | 01-12-06 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.24% | 25 M€ | -2,35% | - | |
0.18% | 43 M€ | +4,17% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 30,33 | -0,43% | 717 143 |
30-05-24 | 30,46 | +4,10% | 606 715 |
29-05-24 | 29,26 | -2,63% | 583 473 |
28-05-24 | 30,05 | +1,21% | 420 042 |
24-05-24 | 29,69 | -2,08% | 309 355 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,11% | 1,41 mld. | |
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |